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The fish early life-stage (FELS) test guideline (OECD 210 or
OCSPP 850.1400) is the most frequently used bioassay for
predicting chronic fish toxicity and supporting aquatic ecological
risk assessments around the world. For each chemical, the FELS
test requires a minimum of 360 fish and 1 to 3 months from test
initiation to termination. Although valuable for predicting fish full
life-cycle toxicity, FELS tests are labor and resource intensive and,
due to an emphasis on apical endpoints, provide little to no
information about chemical mode of action. Therefore, the
development and implementation of alternative testing strategies
for screening and prioritizing chemicals has the potential to
reduce the cost and number of animals required for estimating
FELS toxicity and, at the same time, provides insights into
mechanisms of toxicity. Using three reference chemicals with well-
established yet distinct adverse outcome pathways (AOPs) in early
life stages of fish, we proposed FELS-specific AOPs as conceptual
frameworks for identifying useful chemical screening and
prioritization strategies. The reference chemicals selected as case
studies were a cardiotoxic aryl hydrocarbon receptor agonist
(2,3,7,8-tetrachlorodibenzo-p-dioxin), neurotoxic acetylcholines-
terase inhibitor (chlorpyrifos), and narcotic surfactant (linear
alkylbenzene sulfonate). Using qualitative descriptions for each
chemical during early fish development, we developed generalized
AOPs and, based on these examples, proposed a three-tiered
testing strategy for screening and prioritizing chemicals for FELS
testing. Linked with biologically based concentration-response
models, a tiered testing strategy may help reduce the reliance on
long-term and costly FELS tests required for assessing the hazard
of thousands of chemicals currently in commerce.
Key Words: adverse outcome pathway; high-throughput
screening; zebrafish embryo; fish early life-stage test.
The use of conventional whole-organism (vertebrate) bio-
assays for estimating chronic ecological hazards has been
limited due to low efficiency, high cost, extensive animal use,
and, for aquatic toxicity studies, generation of large volumes of
contaminated water. Moreover, most animal guideline tests
provide little or no informative mechanistic toxicity data due to
the principal focus on apical endpoints such as survival,
growth, and reproduction. Due to these limitations, resource-
efficient alternatives to conventional toxicity testing, including
high-throughput in vitro and in silico screening assays, have
been proposed as key components of a future testing paradigm
for mechanism-based regulatory toxicology and ecotoxicology
(Bradbury et al., 2004; National Research Council, 2007;
Villeneuve and Garcia-Reyero, 2011). However, the predictive
power of molecular or cellular perturbations (e.g., modeled or
detected in vitro) for apical endpoints relevant to ecological
risk assessment (i.e., survival, growth, and reproduction) must
be sufficiently high to minimize uncertainties and provide
meaningful data for regulatory decision making.
To begin identifying useful predictive assays and testing
strategies for regulatory ecotoxicology, Ankley et al. (2010)
recently proposed the use of adverse outcome pathways (AOPs)
as a conceptual framework for summarizing existing knowledge
about linkages between a direct molecular-level initiating event
and an adverse outcome at a level of biological organization
relevant to ecological risk assessment. Predictive linkages are
implicitly defined when developing AOPs, providing a scientific
framework for identification of targeted alternative assays and
models that represent key events at multiple levels of biological
levels of organization. Linked with biologically based concen-
tration-response models (e.g., toxicokinetic and toxicodynamic
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models), these alternative assays, once developed, can facilitate
extrapolation to organism- and population-level endpoints and
significantly decrease reliance on whole-animal regulatory
toxicity tests as the primary source of hazard data for ecological
risk assessment and environmental decision making (National
Research Council, 2007).
As part of a global effort to identify alternative testing
strategies, the ILSI Health and Environmental Sciences
Institute sponsored a workshop from 7 to 9 June 2010 in
Paris, France, entitled ‘‘Development of alternatives to chronic
ecotoxicity tests: predicting early life stage and endocrine-
mediated toxicity in aquatic vertebrate species.’’ More than 50
scientists representing industry, academia, government, and
non-governmental organizations from North America, Europe,
and Asia attended the meeting. The workshop focused on
identifying critical research gaps and associated short- and
long-term research strategies related to the development of
alternatives for chronic fish and amphibian toxicity testing. The
first half of the workshop explored potential alternatives to
a representative, commonly used chronic (long-term) ecotox-
icity test—the fish early life-stage (FELS) test. Two session
topics were considered within this portion of the workshop: (1)
FELS data availability and endpoint evaluation and (2) use of
FELS-specific AOPs to identify potential high- and medium-
throughput tests that could be incorporated into alternative
tiered testing strategies. This paper is focused on key findings
and recommendations derived from the latter session topic.
THE FELS TEST
For regulatory ecotoxicity testing, the FELS test guideline
(OECD 210 or OCSPP 850.1400) was introduced more than 30
years ago as an alternative to longer-term fish full life-cycle tests
(McKim, 1977). Presently, the FELS test is the most frequently
used bioassay for predicting chronic fish toxicity and supporting
ecological risk assessments for pesticides, biocides, pharmaceut-
icals, and industrial chemicals. Based on a recent evaluation of
publically available and registrant-provided data, approximately
425 chemicals across 51 different fish species have been tested
worldwide using the FELS test since 1945 (Norberg-King,
U.S. Environmental Protection Agency [EPA], Duluth, MN,
personal communication). Currently, the most commonly used
freshwater species include rainbow trout (Oncorhynchus mykiss),
fathead minnow (Pimephales promelas), zebrafish (Danio rerio),
and medaka (Oryzias latipes), whereas the most commonly used
saltwater species is sheepshead minnow (Cyprinodon variegatus).
Using static-renewal or flow-through conditions,  60 newly
fertilized eggs per treatment group are equally divided between
a minimum of two replicate chambers and continuously
exposed to a negative and/or vehicle control and at least five
concentrations of a test chemical suspended within vehicle.
Therefore, this design requires a minimum of 360 fish for each
FELS test; however, up to 720 fish per chemical is common
depending on replication, brood stocks, range-finding studies,
and/or preliminary investigations. Fish are exposed until at
least all vehicle-exposed fish are swimming and free feeding.
The typical test includes embryo, eleutheroembryo, larval, and
juvenile stages and is continued until 32 days (fathead and
sheepshead minnows) to 91 days (rainbow trout) post-hatch.
Hatching, mortality, gross morphology, and behavioral abnor-
malities are assessed and documented throughout the entire test
(usually daily), whereas body length and weight (dry and wet)
are assessed at test termination. Based on these endpoints,
hypothesis testing is used to calculate the lowest-observable
effect concentration and no-observable effect concentration
(NOEC) for all endpoints at one or more time-points.
Alternatively, for each endpoint, regression modeling may be
used to model the concentration that adversely affects 10% of
the population relative to controls (EC10). The chronic NOEC
and/or EC10 based on the most sensitive endpoints are then
used as hazard thresholds for regulatory risk assessments.
AOPs DURING EARLY FISH DEVELOPMENT
In the future, a battery of alternative in silico, in vitro, and
in vivo bioassays will likely decrease the number of, and may
ultimately replace, labor-intensive and costly animal experi-
ments performed for chemical hazard assessments. A critical
step in the development of tiered testing approaches, however,
is the identification of common chemically mediated mecha-
nisms of toxicity that could be used to predict potential adverse
effects during fish development. Therefore, to provide a concep-
tual framework for development of alternative testing strategies,
FELS-specific AOPs must first be identified and summarized
using best-available data from the scientific literature. Using
three reference chemicals with well-established yet distinct
modes of action in early life stages of fish, we summarized
three example FELS-specific AOPs to begin conceptualizing
a tiered testing approach for chemical screening and prioritiza-
tion. The reference chemicals we selected as case studies were
a cardiotoxic aryl hydrocarbon receptor (AHR) agonist (2,3,7,8-
tetrachlorodibenzo-p-dioxin [TCDD]), neurotoxic acetylcholines-
terase (AChE) inhibitor (O,O-diethyl O-[3,5,6-trichloro-2-pyridyl]
phosphorothionate or chlorpyrifos [CPF]), and narcotic surfactant
(linear alkylbenzene sulfonate [LAS]). For each chemical, we
briefly summarized the mode of action in early life stages of fish.
Using these qualitative descriptions, we proposed an AOP for
each chemical (Fig. 1) and, based on these three examples,
proposed an overall three-tiered testing scheme for screening and
prioritizing chemicals for FELS testing (Fig. 2).
Case Study #1: TCDD-Induced Cardiotoxicity
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a widely
studied nongenotoxic halogenated aromatic hydrocarbon that is
a by-product of incomplete municipal/industrial waste com-
bustion. TCDD is known to induce adverse effects in humans
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and wildlife, including cancer, reproductive/developmental
effects, immunotoxicity, nephrotoxicity, and cardiovascular
disease (DeVito and Birnbaum, 1994), and is highly lipophilic
(log Kow ¼ 6.58–7.58), exhibits very little solubility in water (19
ng/l at 25C) (ATSDR, 1998), and bioconcentrates within
vertebrates, including fish (log BCF ¼ 3.4–5.1 depending on the
species) (ATSDR, 1998). Due to biological persistence and high
sensitivity of early life stages, TCDD exhibits persistent effects
on teleost health and reproduction (King Heiden et al., 2009) and
has been implicated in declining recruitment and population sizes
of feral fish inhabiting TCDD-contaminated water bodies (e.g.,
lake trout populations within Lake Ontario) (Cook et al., 2003).
Upon entry into cellular cytosol, TCDD is highly specific for
the AHR, a ligand-activated transcription factor identified in
a variety of vertebrates, including species of mammals, birds,
amphibians, bony fishes, cartilaginous fishes, and jawless
fishes (Hahn, 2002). Classic AHR-responsive genes (otherwise
known as the ‘‘Ah gene battery’’) in mammals and fish include
cytochrome P450 1A (CYP1A), NAD(P)H:quinone oxidore-
ductase (NQO1), aldehyde dehydrogenase 3 (ALD3A1), UDP
glucuronosyltransferase (UDPGT), and glutathione transferase
(GST), all phases I and II enzymes that comprise a group of
genes coordinately transcribed and translated in response to
AHR ligand exposure (Nebert et al., 2000). In addition to
dioxin-like chemicals, the AHR pathway and target genes are
responsive to a wide variety of structurally diverse chemicals
(Denison and Heath-Pagliuso, 1998). Other chemicals that
potently activate the AHR likely initiate a TCDD-like AOP.
Peterson et al. published the first comprehensive study of
TCDD-induced early life stage toxicity in zebrafish (Henry
et al., 1997). In this study, 5 h post-fertilization (hpf) zebrafish
embryos (40 embryos per treatment) were exposed for 1 h to
FIG. 1. Proposed AOPs for (A) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)–induced, (B) chlorpyrifos (CPF)–induced, and (C) LAS-induced toxicity in early
life stages of fish development.
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vehicle (0.1% acetone) or increasing concentrations of
[3H]TCDD (35–2100 ng/l ¼ 0.1–6.5nM) and then placed in
clean water until 10 days post-fertilization (dpf). From exposure
initiation to complete hatch (~72 to 96 hpf), there were no
significant differences in embryo survival or time-to-hatch
within all TCDD treatments compared with vehicle controls.
Immediately prior to and following hatch, zebrafish embryos and
larvae exhibited a significant concentration-dependent decrease
in heart rate, blood flow, and swim bladder inflation, as well as
a significant time- and concentration-dependent increase in
pericardial edema, yolk sac edema, craniofacial malformations,
and, as a result, mortality. Interestingly, TCDD-induced heart
malformations and cardiotoxicity preceded systemic toxicity.
This indicates that structural malformations, altered looping, and
decreased cardiomyocyte abundance (due to increased cell death
and/or decreased cell proliferation) within the developing
zebrafish heart leads to retrograde blood flow, ventricular
standstill, and, subsequently, impairments to peripheral circu-
lation and proper organ functioning (Antkiewicz et al., 2005).
AHR is required for TCDD-induced toxicity in zebrafish
embryos, as morpholino (MO)-based knockdown of AHR
translation eliminated cardiotoxicity observed by 72 hpf in
non-MO–exposed control embryos exposed to TCDD (Prasch
et al., 2003; Teraoka et al., 2003).
Case Study #2: CPFO-Mediated Inhibition of Neurite
Outgrowth
Chlorpyrifos (CPF) is a lipophilic (log Kow ¼ 4.96)
organophosphorus insecticide used for broad-spectrum insect
control on ornamentals, turfgrass, and certain vegetable and
field crops. Bioconcentration factors in fish range from
approximately 0.2 to 28,000 depending on the species and
exposure duration (U.S. EPA ECOTOX http://cfpub.epa.gov/
ecotox/), a variation that is likely explained by species-specific
differences in chemical metabolism. Following cellular uptake,
CPF is metabolized to CPF-oxon (CPFO), a potent metabolite
that, at acutely toxic concentrations, inhibits AChE via
phosphorylation of a catalytic serine residue, resulting in
decreased acetylcholine (ACh) hydrolysis, and increased ACh-
induced activation of post-synaptic ACh receptors (Eaton et al.,
2008). For acute exposure events, overstimulation of the
cholinergic synapses often leads to paralysis and death.
Following sublethal exposures during early development,
cholinergic- and non-cholinergic–related toxicity results in
decreased axonogenesis, suppressed locomotor activity, and
altered brain development (Das and Barone, 1999; Li and
Casida, 1998; Slotkin, 1999), leading to persistent neuro-
behavioral effects into adulthood (Dam et al., 2000; Icenogle
et al., 2004; Johnson et al., 2009; Levin et al., 2002).
Mechanisms of CPF-induced neurotoxicity during early fish
development have only recently been characterized using
zebrafish as an animal model. In the absence of gross
malformations, CPF (and CPFO) exposure during zebrafish
embryogenesis decreased baseline locomotor activity and
touch-induced swimming bursts of young larvae (Levin
et al., 2004; Yang et al., 2011). Interestingly, similar to
rodents, neurodevelopmental effects on locomotor activity and
choice accuracy (using a zebrafish maze) appear to persist into
adulthood after transfer to clean water at 5 dpf (Levin et al.,
2003). Although CPFO does not directly affect axial muscles
or abundance of secondary motoneurons, non-teratogenic
concentrations of CPFO do inhibit axonal growth of primary
and secondary motoneurons as well as Rohon-Beard and dorsal
root ganglia sensory neurons (Jacobson et al., 2010; Yang
et al., 2011). Therefore, CPFO-induced functional effects on
zebrafish behavior are directly linked to structural effects on the
developing neural circuitry, phenotypes that are likely due to
AChE inhibition within developing embryos (Behra et al.,
2002; Jacobson et al., 2010; Yang et al., 2011) and/or
alterations in tubulin dynamics due to direct phosphorylation
of microtubules (Jiang et al., 2010).
Case Study #3: LAS-Induced Gill Toxicity and Narcosis
LAS is a complex mixture of anionic surfactants that are
added to many household laundry and dish detergents.
Commercially available alkyl chain lengths vary from 10 to
13 carbons, and sulfophenyl groups can be located at any
nonterminal carbon. LAS is moderately hydrophobic (log Kow
¼ 3.32 for C11.6 LAS), negatively charged at environmental
pH (due to presence of a sulfophenyl group), and exhibits low
bioaccumulation potential (Human and Environmental Risk
Assessment, 2009). In addition, LAS is readily biodegradable
in the environment and undergoes rapid metabolism and
elimination within fish (Tolls et al., 2000). Following
biological uptake, LAS binds to cellular membranes, resulting
in disruption of membrane integrity and fluidity; alterations in
ion homeostasis; aberrant cell signaling; and, at high concen-
trations, cell death (necrosis) (Bernhard and Dyer, 2005; Jifa
et al., 2006; Romani et al., 2003). Within fish, toxicity
increases with increasing LAS alkyl chain length, as longer
hydrophobic alkyl chains or phenyl isomers lead to increased
hydrophobicity and increased binding and disruption of cellular
membranes (Rosen et al., 2001). Therefore, unlike TCDD and
CPF, LAS toxicity is nonspecific and induces a narcotic mode
of action.
In early life stages of fish, gills are the primary target organs
for LAS toxicity. Toxic concentrations of LAS disrupt
epithelium of primary and secondary lamellae (but not chloride
cells), resulting in pathologic alterations (hypertrophy and
edema) that, if persistent, lead to decreased respiration,
systemic hypoxia, loss of equilibrium, and death (Versteeg
and Rawlings, Central Product Safety, Procter & Gamble,
personal communication). Based on partial life cycle and FELS
tests using smallmouth bass, northern pike, fathead minnow,
and white sucker (McKim et al., 1975), fish embryos and
larvae are the most susceptible life stages to LAS-induced
toxicity, with survival representing the most sensitive endpoint
across a wide range of teleosts (Mallett et al., 1997; Versteeg
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and Rawlings, 2003); however, LAS-induced gill toxicity is
reversible, and fish that survive beyond the first 30–60 days of
exposure are reproductively viable (Pickering and Thatcher,
1970). Therefore, effects on larval mortality and population
growth could be predicted based on adverse effects on gills
during early stages of fish development.
TIERED TESTING STRATEGY TO SCREEN AND
PRIORITIZE CHEMICALS FOR FELS TOXICITY TESTING
Although a small subset of regulated chemicals (principally
pesticides) continues to be tested using the FELS test, the need
to screen and prioritize hundreds to thousands of currently
registered chemicals regulated under, e.g., Registration,
Evaluation, Authorization and Restriction of Chemical
(REACH) or Toxic Substances Control Act (TSCA) requires
development of a rapid, cost-efficient, and mechanism-based
tiered testing strategy. Therefore, to begin addressing this
challenge, we propose development of a three-tiered testing
strategy, with the first tier representing high-throughput AOP-
based in vitro (cell-based) assays; the second tier representing
medium-to-high-throughput in vivo (zebrafish embryo) assays;
and the highest tier representing the current FELS guideline
test (Fig. 2).
The primary goal of this tiered strategy would be to identify
rapidly a subset of potentially hazardous chemicals for FELS
testing using the current regulatory guideline (OECD 210 or
OCSPP 850.1400). Although this approach is tailored to
chemical screening and prioritization programs, we recognize
that the application and progression of this tiered testing
scheme may be dependent on the specific needs and risk
assessment objectives of regulatory program(s) around the
world. In addition, although the proposed strategy is illustrated
using three chemical-specific AOPs, this tiered approach must
be expanded to a broad range of toxicologically relevant AOPs
in order to provide a reliable and effective testing strategy that
accounts for concentration-dependent multiple mechanisms of
toxicity within and across chemical classes. Based on
comparisons to positive and negative reference chemicals for
each assay, hazard thresholds will need to be developed within
and across each testing tier to determine whether additional
higher-tier testing is warranted. Moreover, for tier 1 and 2
assays, the application of biologically based concentration-
response modeling (e.g., toxicokinetic and toxicodynamic
models) will be critical to accurately extrapolate findings from
cells (tier 1) and embryos (tier 2) to later life stages of fish
development (tier 3).
Tier 1: High-Throughput In Vitro Screening
Tier 1.1–AHR-specific reporter assays. Based on the
mechanism of TCDD-induced cardiotoxicity in zebrafish,
in vitro luciferase reporter assays using recombinant zebrafish
AHR2 are likely valuable for predicting AHR-mediated
developmental abnormalities and mortality in early life stages
of fish. Given known intra- and interspecies variation in AHR
isoform functionalities within teleosts (Hahn, 2002), additional
high-throughput and multiplexed fish AHR-specific luciferase
reporter assays may be needed to develop models that can
account for genetic variation of feral teleosts to AHR activation
by dioxin-like chemicals. Full-length AHR isoforms (e.g.,
AHR1, AHR2, etc.) should be isolated from one or more
model FELS test teleosts (e.g., fathead minnow, medaka,
zebrafish, and rainbow trout) and cloned into commercially
available expression vectors. Expression constructs for func-
tional zebrafish and rainbow trout AHRs are currently avail-
able (Abnet et al., 1999), whereas functional expression
constructs for fathead minnow, medaka, and sheepshead
minnow AHRs will need to be developed. For high-throughput
assays, these constructs would be individually transfected into
an AHR-negative mammalian or fish host cell line, and
FIG. 2. Proposed three-tiered testing strategy for screening and prioritizing chemicals for FELS toxicity testing.
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AHR-driven luciferase reporter activity, based on a fish aryl
hydrocarbon response element–driven reporter vector—would
be quantified following a 24- to 48-h exposure to positive
controls (e.g., TCDD, benzo[a]pyrene, etc.), negative controls,
or test chemicals in concentration-response format. The
potency of test chemicals (based on EC50s) at non-cytotoxic
concentrations would be compared with reference AHR
agonists and negative controls to determine the potential for
AHR activation and toxicity within FELS. Luciferase reporter
induction thresholds that trigger tier 2 testing will need to be
defined based on the magnitude of AHR activation known to
induce developmental malformations in early life stages of fish.
Tier 1.2–Axonal growth assays. The toxicity of neurotoxic
compounds such as AChE inhibitors is generally associated or
paralleled by inhibition of neurite outgrowth. Therefore, high-
throughput cell line–based systems capable of identifying
whether neurotoxic chemicals exhibit the potential to inhibit
axonal growth of fish-specific sensory neurons and/or moto-
neurons should be developed. Although numerous mammalian
lines are available, the use of fish-specific neuronal cell lines
will likely minimize uncertainties with extrapolating from
mammals to fish; however, to date, the comparative sensitivity
of mammalian versus fish neuronal cells to chemical exposure
has not been directly tested. To our knowledge, the only
immortal fish-specific neuronal line available is the rainbow
trout brain cell line developed by Niels Bols at the University
of Waterloo (Ontario, Canada). For high-throughput assays,
axonal growth would be quantified using automated high-
content imaging following a 24- to 48-h exposure to positive
controls (e.g., CPFO, synthetic pyrethroids, etc.), negative
controls, and test chemicals in concentration-response format.
In addition, enzymatic or biochemical assays could be used to
assess whether decreased axonal growth is associated with
target receptor inhibition (e.g., AChE), activation (e.g.,
nicotinic ACh receptors), or modulation (e.g., Naþ channels).
The potency of test chemicals (based on EC50s) at non-
cytotoxic concentrations would be compared with reference
neurotoxicants and negative controls to determine the potential
for neurotoxicity within FELS. Thresholds for axonal growth
inhibition that trigger tier 2 testing will need to be defined
based on the magnitude of neurite growth inhibition known to
result in behavioral effects in early life stages of fish.
Tier 1.3–Gill cell viability assays. High-throughput cell
line–based systems should be developed to identify whether
narcotic chemicals exhibit the potential to disrupt gill cell
epithelium and viability. Immortal epithelial cells derived from
a primary culture of rainbow trout gills (RTgill-W1) are
currently available from ATCC (cat. no. CRL-2523) (Bols
et al., 1994), precluding the need to develop a new fish-specific
gill cell line. For high-throughput assays, gill cell membrane
integrity and viability should be quantified using standard live/
dead viability assays (Dayeh et al., 2004; Schirmer et al., 1997,
1998) following a 24- to 48-h exposure to positive controls
(e.g., LAS, alkylphenols, etc.), negative controls, or test
chemicals in concentration-response format. The potency of
test chemicals (based on EC50s) would be compared with
reference narcotic chemicals and negative controls to determine
the potential for gill epithelium disruption within early life
stages of fish. Gill cell viability thresholds that trigger tier 2
testing will need to be defined based on the magnitude of gill
epithelium disruption known to affect survival of early life
stages of fish.
Tier 1.n–Additional assays and FELS AOPs. Tier 1 assays
should be developed to address the potential for chemical
metabolism, as these data will be critical for better un-
derstanding chemical half-life and persistence within early life
stages of fish. To account for potential chemical metabolism,
fish-specific hepatocyte lines should be used to assess the rate
of metabolism relative to positive and negative reference
chemicals. Hepatocytes derived from one or more model FELS
test teleosts would be ideal, and model teleost(s) used for
metabolism assays should be identical to species used for other
tier 1 assays. In addition, although freshly isolated hepatocyte
suspensions would be ideal, the use of immortal cell lines
would greatly facilitate the development and application of
high-throughput assays, as well as significantly reduce (or
eliminate) the need for additional use of adult fish. Immortal
hepatocytes derived from normal rainbow trout liver (RTL-
W1) are currently available within Niels Bols’ laboratory (Lee
et al., 1993) and, similar to primary cultures of rainbow trout
hepatocytes, are sensitive to polycyclic aromatic hydrocarbon–
mediated induction of cytochrome P450 1A (Behrens et al.,
2001).
Importantly, implementation of only three assays would not
account for other toxicologically relevant AOPs during FELS
development, potentially undermining the confidence in tier 1
as a priority-setting tool. Therefore, a tier 1 battery should
include high-throughput screening assays relevant to other
known FELS AOPs, and research should be directed toward
systematically characterizing other AOPs related to FELS
toxicity. For example, using the same host cell lines, tier 1.1
reporter assays may be altered to address the potential
activation of a broad range of nuclear receptors by developing
expression and reporter constructs specific to other nuclear
receptor–mediated pathways (e.g., estrogen, androgen, and
peroxisome proliferator–activated receptors). In theory, all
toxicologically relevant FELS AOPs should be represented
with an appropriate assay in order to account for concentration-
dependent multiple mechanisms of toxicity within and across
chemical classes. Using a battery of tier 1 assays, a ‘‘positive’’
finding from one or more of the tier 1 AOP-specific assays
would trigger tier 2 testing, whereas ‘‘negative’’ findings from
all tier 1 assays would preclude the need to conduct additional
testing within fish embryos and larvae. A ‘‘positive’’ finding
may occur when the test chemical EC50 is within the range of
EC50s for positive controls or when the ratio of baseline
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(nonspecific) toxicity to specific biological effects is similar to
positive controls. A ‘‘negative’’ finding may occur when the
test chemical EC50 is orders of magnitude higher than EC50s
for positive controls or when the test chemical only induces
baseline (nonspecific) toxicity at high concentrations. Although
comprehensive coverage does not preclude the potential for
false negatives, a manageable and appropriately sized battery
of high-throughput tier 1 assays should be sufficient to identify
chemicals exhibiting potential FELS toxicity. As a potential
testing requirement for chemical registrations in the future, this
approach, while not perfect, would represent an improvement
over the current strategy that relies on minimal to no hazard
testing for most chemicals in commerce.
Tier 2: Medium-to-High-Throughput In Vivo Screening
Definitions of protected and nonprotected stages of fish for
regulatory testing and scientific experimentation vary widely
around the world (Halder et al., 2010). According to current
legislation within the European Union, fish embryos (pre-hatch
stages) and eleuthereoembryos, the time-period between
immediately post-hatch and stages of independent feeding,
are nonprotected life stages and are considered as alternative
testing models (Belanger et al., 2010; Embry et al., 2010;
Halder et al., 2010; Scholz et al., 2008). Other regulatory
jurisdictions do not clearly distinguish protected and non-
protected stages of fish but do provide indications based on
acceptance of certain assays or through the encouragement of
new assays and approaches (e.g., in Japan and the United
States).
In contrast to cell-based assays, fish embryos provide the
complexity and interaction of an intact organism, enabling the
evaluation of chemically induced effects on multiple target
organs. Given the accessibility, global use, and research tools
available for zebrafish, a tier 2 zebrafish embryo toxicity assay
should be implemented to predict the potential toxicity of
chemicals on early life stages of model FELS test teleosts. As
part of the chemical screening and prioritization research
(ToxCast) program within the U.S. EPA, a zebrafish
developmental toxicity assay has been used by EPA to evaluate
the potential human health effects of 320 ToxCast Phase-I
chemicals (Padilla et al., 2009). In this assay, zebrafish are
continuously exposed in 96-well plates from late gastrula stage
(approximately 8 hpf) to 5 dpf and then visually assessed for
mortality and gross malformations at 6 dpf. In collaboration
with EPA, this assay should, in addition to gross assessments
of mortality and morphology, be modified to include high-
content quantitative imaging of cardiovascular development,
neurogenesis, and gill morphology using whole-mount immu-
nofluorescence-based approaches. In addition, for functional
assessments of cardiotoxicity and neurotoxicity, larval heart
rates and behavior (locomotor activity and photomotor re-
sponse) could be rapidly quantified within developing zebrafish
embryos (Burns et al., 2005; Kokel et al., 2010; MacPhail
et al., 2009; Milan et al., 2003; Rihel et al., 2010). These live
imaging assays have the potential to classify accurately
cardiotoxic and neurotoxic AOPs and could be very useful
for development of predictive models of cardiotoxicity and
neurotoxicity.
Overall, a 3- to 5-day zebrafish embryo toxicity assay would
be consistent with existing definitions of embryo and
eleuthereoembryo life stages (Belanger et al., 2010), as well
as considerations under the European Animal Protection
Directive where protected stages of fish occur at the transition
to exogenous feeding (Halder et al., 2010). Based on this tier 2
assay, target organ toxicity thresholds that trigger tier 3 FELS
testing will need to be defined based on concentration-by-time
response comparisons to positive controls with known early
life stage toxicity.
Tier 3: Low-Throughput FELS Test (OECD 210 or OCSPP
850.1400)
The final testing tier would represent the current FELS test
guideline. Applied in a chemical screening and hazard
characterization context, this tier would only be implemented
if a chemical tested positive based on the previous two testing
tiers. Following tier 2 testing, a ‘‘positive’’ finding may occur
when the test chemical’s EC50 for organ-specific effects is
within the range of EC50s for positive controls. Based on this
definition, these chemicals would likely have a higher
probability of inducing persistent chronic effects and, conse-
quently, would be viewed as higher priority targets for tier 3
testing.
SHORT- AND LONG-TERM RESEARCH GOALS
In the short term (3–5 years), the following research
objectives are recommended to implement a tiered testing
strategy as outlined above. First, toxicologically relevant AOPs
should be identified, described, and annotated to provide
a conceptual and scientific foundation for identification and
development of tier 1 assays. Recently, an open-source and
open-knowledge program named Effectopedia (available at
http://www.softpedia.com/get/Science-CAD/Effectopedia.shtml)
was released in late 2010 by the International QSAR
Foundation to provide a Wiki-based tool for describing,
cataloging, and updating AOPs in an encyclopedic manner.
Using Wiki-based software such as Effectopedia, the global
scientific community can collectively identify and systemati-
cally annotate currently known and newly discovered FELS-
specific AOPs relevant to chemical toxicity. Following
annotation, tier 1 assays and corresponding reference chemicals
may then be identified based on a catalog of FELS AOPs.
Following identification of potential tier 1 assays, positive
and negative reference chemicals for currently known FELS
AOPs should be identified for tiers 1 and 2 assays using criteria
similar to those previously described (Schirmer et al., 2008). At
minimum, positive reference chemicals should (1) exhibit
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a range of potencies (low to moderate to high) for target
receptors or endpoints represented within tier 1 assays, (2)
exhibit sufficient hydrophobicity (log Kow > 2) to ensure
adequate chemical movement across the chorion during
embryogenesis for tier 2 assays, and (3) have documented
target organ toxicity within early life stages of fish based on
existing FELS toxicity data derived from the FELST OECD
210 or OPPTS 850.1400 guideline. Once these chemicals have
been identified, tier 1 assays should be developed and tested
using the general strategy described above. Using reference
chemicals for neurotoxic AOPs, the comparative sensitivity of
rainbow trout brain cells versus commonly used mammalian
neuronal cell lines should be assessed to determine whether
mammalian neurons could be used as surrogate models for fish
neurons. Following completion of tier 1 testing with reference
chemicals, the EPA’s ToxCast zebrafish developmental
toxicity assay should be formally adapted and implemented
as a tier 2 assay using tier 1 reference chemicals. This assay
should rely on a robust strain of wild-type zebrafish exhibiting
low background mortality rates during embryogenesis and, at
minimum, include assessments of heart rate, behavior (loco-
motor activity and photomotor response), cardiovascular
development, neurogenesis, and gill morphology. Finally,
based on comparisons of tiers 1 and 2 results, false-negative
and -positive error rates should be quantified and, if necessary,
non-predictive tier 1 assays should be removed and new tier 1
tests should be developed to improve the ability to predict
effects observed within tier 2 assays.
In the long term (5–10 years), the early life stage toxicity of
tiers 1 and 2 reference chemicals should be tested (if data are
not already available) using a modified OECD 210 or OPPTS
850.1400 guideline that includes endpoints reflecting AOPs
represented within the tier 1 assays. These results should then
be compared with results from tiers 1 and 2 assays to quantify
the ability of high- and medium-throughput assays to predict
FELS toxicity. Following successful completion of pilot tiers 1
and 2 tests, a large-scale inter-laboratory validation of these
assays must be developed and completed prior with adoption
by regulatory authorities. Multitier assay validation would
include the use of a wide range of chemical classes that cover
multiple FELS AOPs. Finally, based on comparisons of tiers 2
and 3 results, false-negative and -positive error rates for
predicting FELS toxicity should be quantified, and, if
necessary, the tier 2 assay should be modified to improve the
ability to predict effects observed within tier 3 assays. These
modifications may include the use of (1) additional endpoints at
the histologic or biomarker level, (2) transgenic strains or
reverse genetic approaches (e.g., morpholino knockdown), and/or
(3) pharmacological co-exposures (e.g., co-exposure with com-
petitive inhibitor) to help uncover target pathways. Finally, as new
FELS AOPs are discovered and characterized, a Wiki-based
tool such as Effectopedia should be continuously updated in
order to augment the existing catalog of known FELS AOPs.
Following consensus within the scientific community, new tier
1 assays and reference chemicals that represent newly
discovered FELS AOPs may then be recommended for
development and validation as described above.
CONCLUSIONS
In conclusion, using FELS-specific AOPs as conceptual
frameworks, the development and implementation of a tiered
testing approach will likely enable rapid screening and
identification of chemicals with the potential to cause early
life stage toxicity, allowing for effects-based identification of
high-priority targets for additional tiers of testing that utilize
integrated and complex biological models. This strategy would
preclude the need to (1) rely on low-throughput FELS tests for
each chemical hazard assessment or (2) conduct chemical
hazard assessments in the absence of biological effects data. As
outlined above, we propose development of a three-tiered
testing strategy that includes high-throughput cell-based
assays, medium-to-high-throughput zebrafish embryo toxicity
assays, and low-throughput guideline FELS tests. Although our
recommendations are based on three example AOPs, the
proposed approach must account for other toxicologically
relevant AOPs by developing a battery of FELS AOP-based
tier 1 assays. In general, the use of AOPs for assay
identification holds promise for facilitating the implementation
of alternatives to animal testing for environmental toxicology
and risk assessment. Although the proposed methodology is
tailored for chemical screening and prioritization, in the future,
the use of alternative tests (e.g., tiers 1 and 2) alone may
provide the basis for regulatory decision making and
environmental risk assessment.
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